Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 5, 2010, Pages 1441-1448

  Iñarrairaegui, Mercedes ^a   Martinez Cuesta, Antonio ^a   Rodríguez, MacArena ^a   Bilbao, J Ignacio ^a   Arbizu, Javier ^a   Benito, Alberto ^a   Alegre, Félix ^a   D'Avola, Delia ^a,b   Herrero, J Ignacio ^a,b   Quiroga, Jorge ^a,b   Prieto, Jesús ^a,b   Sangro, Bruno ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

90Y radioembolization; Hepatocellular carcinoma; Prognostic factors; Survival

Indexed keywords

CONFIDENCE INTERVAL; FETOPROTEIN; HAZARD RATIO; HEPATOCELLULAR CARCINOMA; IN-CONTROL; MULTI VARIATE ANALYSIS; NON-TARGETED; OVERALL SURVIVAL; PROGNOSTIC FACTORS; RADIOEMBOLIZATION; SURVIVAL; TUMOR SIZE; UNIVARIATE ANALYSIS; YTTRIUM-90;

LIVER; MULTIVARIANT ANALYSIS; PATIENT MONITORING; TUMORS; YTTRIUM;

YTTRIUM ALLOYS;

ALPHA FETOPROTEIN; YTTRIUM 90; DIAGNOSTIC AGENT; MACROSALB TC 99M; MICROSPHERE; RADIOPHARMACEUTICAL AGENT; YTTRIUM;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SIZE; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HUMAN; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; ARTIFICIAL EMBOLISM; DISEASE COURSE; LIVER TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PATIENT SELECTION; RETROSPECTIVE STUDY; SCINTISCANNING; SURVIVAL; TUMOR VOLUME;

AGED; ALPHA-FETOPROTEINS; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TUMOR BURDEN; YTTRIUM RADIOISOTOPES;

EID: 77955505767     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.07.006     Document Type: Article

References (25)

1. D.M. Parkin, F. Bray, and J. Ferlay Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
3. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival Hepatology 37 2003 429 442
4. J.W. Chung, J.H. Park, and J.K. Han Hepatocellular carcinoma and portal vein invasion: Results of treatment with transcatheter oily chemoembolization AJR Am J Roentgenol 165 1995 315 321
5. H.S. Lee, J.S. Kim, and I.J. Choi The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study Cancer 79 1997 2087 2094
6. S.D. Ryder Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults Gut 52 Suppl. 3 2003 iii1 8
7. K. Takayasu, S. Arii, and I. Ikai Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients Gastroenterology 131 2006 461 469
8. J.M. Llovet, S. Ricci, and V. Mazzaferro Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
9. B.I. Carr Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients Liver Transpl 10 2004 S107 S110
10. J.F. Geschwind, R. Salem, and B.I. Carr Yttrium-90 microspheres for the treatment of hepatocellular carcinoma Gastroenterology 127 2004 S194 S205
11. L.M. Kulik, B.I. Carr, and M.F. Mulcahy Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis Hepatology 47 2008 71 81
12. W.Y. Lau, S. Ho, and T.W. Leung Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres Int J Radiat Oncol Biol Phys 40 1998 583 592
13. B. Sangro, J.I. Bilbao, and J. Boan Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma Int J Radiat Oncol Biol Phys 66 2006 792 800
14. R. Salem, R.J. Lewandowski, and B. Atassi Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): Safety, tumor response, and survival J Vasc Interv Radiol 16 2005 1627 1639
15. J.E. Dancey, F.A. Shepherd, and K. Paul Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres J Nucl Med 41 2000 1673 1681
16. A. Kennedy, S. Nag, and R. Salem Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the radioembolization brachytherapy oncology consortium Int J Radiat Oncol Biol Phys 68 2007 13 23
17. J. Bruix, M. Sherman, and J.M. Llovet Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
18. J. Boan, M. Valero, and J. Arbizu Improving treatment design by image fusion techniques J.I. Bilbao, M.F. Reiser, Liver radioembolization with 90Y microspheres 2008 Springer-Verlag Berlin-Heidelberg 61 75
19. M. Iñarrairaegui, and B. Sangro Results in hepatocellular carcinoma J.I. Bilbao, M.F. Reiser, Liver radioembolization with 90Y microspheres 2008 Springer-Verlag Berlin-Heidelberg 107 116
20. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
21. B. Sangro, B. Gil-Alzugaray, and J. Rodriguez Liver disease induced by radioembolization of liver tumors: Description and possible risk factors Cancer 112 2008 1538 1546
22. G. Ercolani, G.L. Grazi, and M. Ravaioli Liver resection for hepatocellular carcinoma on cirrhosis: Univariate and multivariate analysis of risk factors for intrahepatic recurrence Ann Surg 237 2003 536 543
23. A new prognostic system for hepatocellular carcinoma A retrospective study of 435 patients: The Cancer of the Liver Italian Program (CLIP) investigators Hepatology 28 1998 751 755
24. Y. Nakashima, O. Nakashima, and C.C. Hsia Vascularization of small hepatocellular carcinomas: Correlation with differentiation Liver 19 1999 12 18
25. J.M. Llovet, M.I. Real, and X. Montana Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial Lancet 359 2002 1734 1739